XML 49 R40.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Entities - Pro Forma Information (Details) - Entasis Therapeutics Holdings Inc - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Business Acquisition [Line Items]        
Revenue $ 108,220 $ 100,806 $ 198,279 $ 186,324
Net income 17,221 34,140 55,248 144,490
Net income attributable to Innoviva stockholders $ (3,306) $ 17,063 $ 15,727 $ 116,130